These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10094259)

  • 1. Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients.
    Sarchielli P; Presciutti O; Pelliccioli GP; Tarducci R; Gobbi G; Chiarini P; Alberti A; Vicinanza F; Gallai V
    Brain; 1999 Mar; 122 ( Pt 3)():513-21. PubMed ID: 10094259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.
    Husted CA; Goodin DS; Hugg JW; Maudsley AA; Tsuruda JS; de Bie SH; Fein G; Matson GB; Weiner MW
    Ann Neurol; 1994 Aug; 36(2):157-65. PubMed ID: 8053651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging axonal damage of normal-appearing white matter in multiple sclerosis.
    Fu L; Matthews PM; De Stefano N; Worsley KJ; Narayanan S; Francis GS; Antel JP; Wolfson C; Arnold DL
    Brain; 1998 Jan; 121 ( Pt 1)():103-13. PubMed ID: 9549491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
    Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
    Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy.
    Ruiz-Peña JL; Piñero P; Sellers G; Argente J; Casado A; Foronda J; Uclés A; Izquierdo G
    BMC Neurol; 2004 Jun; 4():8. PubMed ID: 15191618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
    He J; Inglese M; Li BS; Babb JS; Grossman RI; Gonen O
    Radiology; 2005 Jan; 234(1):211-7. PubMed ID: 15528260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).
    Schneider R; Bellenberg B; Hoepner R; Kolb EM; Ellrichmann G; Haghikia A; Gold R; Lukas C
    PLoS One; 2017; 12(4):e0176415. PubMed ID: 28445498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T.
    Pan JW; Hetherington HP; Vaughan JT; Mitchell G; Pohost GM; Whitaker JN
    Magn Reson Med; 1996 Jul; 36(1):72-7. PubMed ID: 8795023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis.
    Hiehle JF; Lenkinski RE; Grossman RI; Dousset V; Ramer KN; Schnall MD; Cohen JA; Gonzalez-Scarano F
    Magn Reson Med; 1994 Sep; 32(3):285-93. PubMed ID: 7984060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis.
    Fernando KT; McLean MA; Chard DT; MacManus DG; Dalton CM; Miszkiel KA; Gordon RM; Plant GT; Thompson AJ; Miller DH
    Brain; 2004 Jun; 127(Pt 6):1361-9. PubMed ID: 15128615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study.
    Duan Y; Liu Z; Liu Y; Huang J; Ren Z; Sun Z; Chen H; Dong H; Ye J; Li K
    Acta Radiol; 2017 Sep; 58(9):1132-1137. PubMed ID: 28173728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady-state metabolism and its relationship to conventional imaging.
    Kirov II; Liu S; Tal A; Wu WE; Davitz MS; Babb JS; Rusinek H; Herbert J; Gonen O
    Hum Brain Mapp; 2017 Aug; 38(8):4047-4063. PubMed ID: 28523763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High resolution proton NMR spectroscopy of multiple sclerosis lesions.
    Davies SE; Newcombe J; Williams SR; McDonald WI; Clark JB
    J Neurochem; 1995 Feb; 64(2):742-8. PubMed ID: 7830068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton magnetic resonance spectroscopy in primary and secondary progressive multiple sclerosis.
    Cucurella MG; Rovira A; Río J; Pedraza S; Tintoré MM; Montalbán X; Alonso J
    NMR Biomed; 2000 Apr; 13(2):57-63. PubMed ID: 10797633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of energy metabolism in multiple sclerosis measured in vivo with diffusion-weighted spectroscopy.
    Bodini B; Branzoli F; Poirion E; García-Lorenzo D; Didier M; Maillart E; Socha J; Bera G; Lubetzki C; Ronen I; Lehericy S; Stankoff B
    Mult Scler; 2018 Mar; 24(3):313-321. PubMed ID: 28394203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton magnetic resonance spectroscopy of normal appearing white matter in asymptomatic relatives of multiple sclerosis patients.
    Siger-Zajdel M; Selmaj K
    Eur J Neurol; 2006 Mar; 13(3):296-8. PubMed ID: 16618349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis.
    Inglese M; Li BS; Rusinek H; Babb JS; Grossman RI; Gonen O
    Magn Reson Med; 2003 Jul; 50(1):190-5. PubMed ID: 12815694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis.
    Staffen W; Zauner H; Mair A; Kutzelnigg A; Kapeller P; Stangl H; Raffer E; Niederhofer H; Ladurner G
    J Neuropsychiatry Clin Neurosci; 2005; 17(3):357-63. PubMed ID: 16179658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced axonal metabolism during early natalizumab treatment in relapsing-remitting multiple sclerosis.
    Wiebenga OT; Klauser AM; Schoonheim MM; Nagtegaal GJ; Steenwijk MD; van Rossum JA; Polman CH; Barkhof F; Pouwels PJ; Geurts JJ
    AJNR Am J Neuroradiol; 2015 Jun; 36(6):1116-23. PubMed ID: 25742985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis.
    Sastre-Garriga J; Ingle GT; Chard DT; Ramió-Torrentà L; McLean MA; Miller DH; Thompson AJ
    Arch Neurol; 2005 Apr; 62(4):569-73. PubMed ID: 15824254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.